News for 'drug control'

How Serum and Bharat battled for COVID-19 vaccine

How Serum and Bharat battled for COVID-19 vaccine

Rediff.com23 Apr 2021

There were apprehensions in the SII about rival Bharat Biotech's 'indigenous' tag, opening up shortcuts for it. One senior person, who was very familiar with the sector, told me, 'The message has gone out from the very top. Somani (V G Somani -- drug controller general of India) has told me "Bharat ka karna hai".' A fascinating excerpt from Abantika Ghosh's Billions Under Lockdown: The Inside Story Of India's Fight Against COVID-19.

Govt expects speedy launch of single-dose Sputnik Light vaccine

Govt expects speedy launch of single-dose Sputnik Light vaccine

Rediff.com27 May 2021

The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application and regulatory approval procedures for the jab to boost the country's vaccination drive, sources said.

Before Obama visit, US drug firms lobby for ease of doing business

Before Obama visit, US drug firms lobby for ease of doing business

Rediff.com5 Jan 2015

Unlike India, the US is a free-pricing market.

Panel to discuss drug price cuts

Panel to discuss drug price cuts

Rediff.com4 Mar 2006

Kangana to face drugs probe amid row with Maha govt

Kangana to face drugs probe amid row with Maha govt

Rediff.com11 Sep 2020

The Maharashtra HM had said on Tuesday that the Mumbai police will probe allegations by actor Adhyayan Suman that Ranaut took drugs.

Govt in talks with Pfizer, J&J for supply of vaccines to India

Govt in talks with Pfizer, J&J for supply of vaccines to India

Rediff.com2 Jun 2021

The central government is importing COVID-19 vaccines and is in talks with COVID-19 vaccine manufacturers Pfizer and Johnson & Johnson, Union Minister of State for Home Affairs G Kishan Reddy said.

ICMR doing 3 studies on post-Covid heart attack among young

ICMR doing 3 studies on post-Covid heart attack among young

Rediff.com21 Jul 2023

The Indian Council of Medical Research is conducting three different studies to ascertain the facts regarding rising cases of cardiac arrest after the pandemic, Mandaviya said in response to a question in the Lok Sabha.

Pharma firms to be hit as drug regulator caps prices

Pharma firms to be hit as drug regulator caps prices

Rediff.com19 Sep 2014

Currently, the govt directly caps prices of 348 formulations at the average price of all medicines in a particular segment with at least 1% market share

US regulator fast-tracks approval for Wockhardt drugs

US regulator fast-tracks approval for Wockhardt drugs

Rediff.com1 Sep 2014

These drugs will be entering in their global Phase -3 clinical trials early next year.

Ramdev withdraws 'allopathy' remarks after furore

Ramdev withdraws 'allopathy' remarks after furore

Rediff.com24 May 2021

However, he also said traditional ayurveda, yoga and naturopathy have also controlled and provided permanent solution to several complex diseases like blood pressure, thyroid, sugar, arthritis, hepatitis and asthma.

Wockhardt told to pull out analgesic batches

Wockhardt told to pull out analgesic batches

Rediff.com14 Feb 2013

Regulator mentions Wockhardt as manufacturer but firm says it only markets drug.

Regulator wants end to antibiotic misuse

Regulator wants end to antibiotic misuse

Rediff.com10 Sep 2012

Orders surprise inspections at chemists and pharma stores.

Judo: 'Kelmendi OK to refuse France drug test'

Judo: 'Kelmendi OK to refuse France drug test'

Rediff.com10 Aug 2016

Judo's governing body said that athletes were not obliged to take unscheduled drug tests when training in France in June and that those who refused, including Kosovo's gold medallist Majlinda Kelmendi, subsequently tested negative the next week.

India partly revokes Roche cancer drug patent

India partly revokes Roche cancer drug patent

Rediff.com5 Aug 2013

Roche has already adapted its business model in India to increase affordable access to drugs and try to stave off trouble from India's patent authorities.

Expert panel recommends granting emergency nod to Oxford vaccine

Expert panel recommends granting emergency nod to Oxford vaccine

Rediff.com2 Jan 2021

As for Bharat Biotech, the Subject Expert Committee (SEC) on COVID-19 of the CDSCO asked the firm to expedite volunteer recruitment for the ongoing clinical trial and said it may conduct interim efficacy analysis for further consideration of restricted emergency use approval for its vaccine Covaxin, they stated.

Can An Ischemic Stroke Cause Sudden Death?

Can An Ischemic Stroke Cause Sudden Death?

Rediff.com8 Apr 2024

When the artery going to the brain gets clogged or closes off, and a part of the brain goes without blood for too long, it is called an ischemic stroke.

COVID-19 vaccine Covaxin enters phase-3 trials

COVID-19 vaccine Covaxin enters phase-3 trials

Rediff.com16 Nov 2020

Covaxin is being developed by Bharat Biotech, in collaboration with the Indian Council of Medical Research - National Institute of Virology.

Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod

Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod

Rediff.com28 Dec 2023

As of now, Gennova Biopharmaceuticals has launched a vaccine, Gemcovac-OM, which is based on the Omicron variant.

DU, JNU students arrested in New Year drugs bust

DU, JNU students arrested in New Year drugs bust

Rediff.com30 Dec 2017

The NCB claimed that the students were both addicts and suppliers of these drugs.

Why birth control pills may be dangerous for you

Why birth control pills may be dangerous for you

Rediff.com5 Jan 2019

Birth control pills increase the risk of ischemic strokes.

Covid vaccination for children likely to start soon: Mandaviya

Covid vaccination for children likely to start soon: Mandaviya

Rediff.com28 Jul 2021

Union Health Minister Mansukh Mandaviya on Tuesday told Bharatiya Janata Party MPs that Covid vaccination for children is likely to start soon, sources said.

Govt to reduce cancer drug prices soon

Govt to reduce cancer drug prices soon

Rediff.com3 Dec 2009

Replying to supplementaries during Question Hour in the Lok Sabha, minister of state for chemicals and fertilisers Srikant Jena said the National Pharmaceutical Pricing Authority has been asked to look into demands for bringing 23 anti-cancer drugs within the ambit of price control.

India-Pak sign MoU against drug trafficking

India-Pak sign MoU against drug trafficking

Rediff.com13 Sep 2011

India and Pakistan on Tuesday agreed to enhance cooperation through "effective and sustained steps" to control illicit drug trade and signed a Memorandum of Understanding to boost efforts to prevent the trafficking of narcotics and precursor chemicals.

Delhi factory fire: Death toll climbs to 11, 4 injured

Delhi factory fire: Death toll climbs to 11, 4 injured

Rediff.com16 Feb 2024

The fire was preceded by a blast and soon it spread to nearby buildings, including a drug rehabilitation centre and eight shops.

India Inc finds stem cells a healthy business

India Inc finds stem cells a healthy business

Rediff.com14 Jul 2009

Bangalore-based Stempeutics Research received clearance from the Drug Controller General of India to conduct human clinical trials to develop drugs using stem cells. With this, India became the first country after the US to allow human clinical trials to develop drugs by using dormant cells in the body that have natural regeneration capabilities. Once injected into a patient, the stem cells can be controlled with a simple magnet to direct them to the damaged area and cure

Parl panel advises caution in emergency approval of vaccine

Parl panel advises caution in emergency approval of vaccine

Rediff.com21 Dec 2020

In a report submitted Monday to Rajya Sabha chairman and Vice President M Venkaiah Naidu, the Parliamentary Standing Committee on Home Affairs also said there was a need for a comprehensive public health law to keep a tab on private hospitals and check black-marketing of medicines.

509 essential drugs to be costlier

509 essential drugs to be costlier

Rediff.com8 Apr 2015

The government regulates prices of all other medicines.

Hetero's generic version of remdesivir to be sold @ Rs 5,400/vial

Hetero's generic version of remdesivir to be sold @ Rs 5,400/vial

Rediff.com24 Jun 2020

The company is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which will be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of Maharashtra, Hetero Healthcare said in a statement.

China apologises to Nigeria over fake drugs

China apologises to Nigeria over fake drugs

Rediff.com21 Sep 2009

China has formally apologised to Nigeria for alleged export of fake drugs including some labelled as 'Made in India' by some Chinese firms to the country and assured to take punitive action against those involved in the scandal.

Cop, ex-sarpanch arrested in Jammu terror funding case

Cop, ex-sarpanch arrested in Jammu terror funding case

Rediff.com3 Jan 2024

The Special Investigation Agency (SIA) has arrested two more persons, including a policeman, for allegedly being part of a cross-border narcotic syndicate involved in terror funding in Jammu, officials said on Wednesday.

Phase 3 clinical trial of Oxford vaccine begins in Pune

Phase 3 clinical trial of Oxford vaccine begins in Pune

Rediff.com21 Sep 2020

"We have started the phase-III trials of the vaccine (candidate Covishield). We will administer dose to 150 to 200 volunteers," said Dr Muralidhar Tambe, Dean, Sassoon General Hospital.

All life-saving drugs may come under price cap

All life-saving drugs may come under price cap

Rediff.com25 Oct 2014

NPPA suggests expanding the list of essential medicines whose prices are controlled

DGCI denies emergency use nod to Sputnik-Light vaccine

DGCI denies emergency use nod to Sputnik-Light vaccine

Rediff.com1 Jul 2021

According to the recommendations of the Subject Expert Committee (SEC) meeting held on July 30, which have been approved by the Drugs Controller General of India (DCGI), Sputnik-Light is the same as the component-1 of Sputnik V and as its safety and immunogenicity data in the Indian population has already been generated in a trial here, there seems to be inadequate data and justification for conducting a separate, similar trial.

Kerala prepares action plan for vaccination of teens

Kerala prepares action plan for vaccination of teens

Rediff.com2 Jan 2022

As the COVID-19 vaccination of children falling into the age bracket of 15 to 18 years is scheduled to begin from January 3, the Kerala health department has prepared an action plan for inoculation of all eligible beneficiaries.

Only Covaxin available for 15-18-yr-olds, for now

Only Covaxin available for 15-18-yr-olds, for now

Rediff.com27 Dec 2021

Healthcare and frontline workers and citizens above 60 years of age with comorbidities would be administered the third dose of the same vaccine they had been given before.

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Rediff.com25 Aug 2021

If things go according to plan, the vaccine would be available in the market by the end of this year.

Sameer Wankhede's foreign visits, expensive watches under CBI scanner

Sameer Wankhede's foreign visits, expensive watches under CBI scanner

Rediff.com15 May 2023

The details of FIR made public on Monday show that independent witness K P Gosavi and one Prabhakar Sail, now deceased, were included by the NCB in the Cordelia cruise ship drug raid on October 2, 2021 on the directions of Wankhede.

HC extends protection to Sameer Wankhede till June 23

HC extends protection to Sameer Wankhede till June 23

Rediff.com8 Jun 2023

The case of the CBI is that Wankhede and others accused had allegedly demanded Rs 25 crore bribe from actor Shah Rukh Khan for not framing his son Aryan Khan following alleged seizure of drugs from a cruise ship.

Serum Institute seeks regular marketing approval for Covishield

Serum Institute seeks regular marketing approval for Covishield

Rediff.com25 Oct 2021

If the DCGI grants regular marketing authorisation, Covishied will be the second vaccine in the world to receive such approval.

Drug cos may gain from polluting status review

Drug cos may gain from polluting status review

Rediff.com2 Dec 2008

A segment of drug companies such as tablet and capsule makers may benefit from the government's move to review polluting status of these companies, which may help them save costs on pollution control equipment.